These gene sets included genes upregulated in osteosarcoma cells after knockdown of histone deacetylase HDAC1 (70) as well as genes upregulated in prostate cancer cells after knockdown of PRC2 component EZH2 (71). The gene discussed is EZH2; the disease is prostate carcinoma.